CBD Life Sciences Inc.CBD Life Sciences Inc.CBD Life Sciences Inc.

CBD Life Sciences Inc.

No trades
See on Supercharts
Market capitalization
‪938.49 K‬USD
−0.0002USD
‪−78.57 K‬USD
‪167.15 K‬USD
Beta (1Y)
−114.32

About CBD Life Sciences Inc.


CEO
Lisa Nelson
Headquarters
Scottsdale
Founded
2003
FIGI
BBG000QC3SJ9
CBD Life Sciences, Inc. focuses on identifying, evaluating and acquiring undervalued opportunities with the objective of increasing shareholder value. The company was founded on December 31, 2003 and is headquartered in Scottsdale, AZ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CBDL is 0.0006 USD — it has increased by 10.00% in the past 24 hours. Watch CBD Life Sciences Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CBD Life Sciences Inc. stocks are traded under the ticker CBDL.
CBDL stock has risen by 10.00% compared to the previous week, the month change is a −8.33% fall, over the last year CBD Life Sciences Inc. has showed a −98.17% decrease.
CBDL reached its all-time high on May 19, 2014 with the price of 7,350,000.0000 USD, and its all-time low was 0.0003 USD and was reached on Oct 19, 2022. View more price dynamics on CBDL chart.
See other stocks reaching their highest and lowest prices.
CBDL stock is 50.00% volatile and has beta coefficient of −114.32. Track CBD Life Sciences Inc. stock price on the chart and check out the list of the most volatile stocks — is CBD Life Sciences Inc. there?
Today CBD Life Sciences Inc. has the market capitalization of ‪938.49 K‬, it has increased by 66.67% over the last week.
Yes, you can track CBD Life Sciences Inc. financials in yearly and quarterly reports right on TradingView.
CBDL net income for the last quarter is ‪−295.67 K‬ USD, while the quarter before that showed ‪−67.49 K‬ USD of net income which accounts for −338.08% change. Track more CBD Life Sciences Inc. financial stats to get the full picture.
No, CBDL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CBD Life Sciences Inc. EBITDA is ‪−359.26 K‬ USD, and current EBITDA margin is −13.77%. See more stats in CBD Life Sciences Inc. financial statements.
Like other stocks, CBDL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CBD Life Sciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CBD Life Sciences Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CBD Life Sciences Inc. stock shows the sell signal. See more of CBD Life Sciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.